Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.

The Bard® Recovery® Filter Registry (EVEREST) for Patients Who Are Candidates for an Optional (Retrievable) Inferior Vena Cava Filter That Undergo Placement of the Bard® Recovery® Filter.

This study was designed to assess the safety of retrieval of the Bard Recovery® G2® Filter System. The G2 filter is an FDA-cleared device for inferior vena caval interruption in patients with pulmonary thromboembolism.

Inclusion Criteria:

• The patient is at temporary , increased risk of pulmonary embolism requiring caval interruption

Exclusion Criteria:

• The patient has implanted filter in the IVC or superior vena cava (SVC)
• The patient has a duplicated or left-sided IVC
• The patient has a known untreatable or uncontrollable malignancy
• The patient has severe spinal deformity
• The patient has a creatinine > 2.0 mg/dl
• The patient has a life expectancy of < 6 months